Back to Search
Start Over
The use and impact of monoclonal antibody biologics during pregnancy.
- Source :
-
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2021 Jul 26; Vol. 193 (29), pp. E1129-E1136. - Publication Year :
- 2021
-
Abstract
- Competing Interests: Competing interests: Anne Pham-Huy reports presentation honoraria from the Canadian Society of Allergy and Clinical Immunology and the University of Calgary. She is the chair of Immunize Canada. Karina Top is a co-investigator on grants from GSK, outside the submitted work. She also reports an honorarium from the Canadian Society of Allergy and Clinical Immunology, payment for expert testimony from the Ontario Ministry of the Attorney General and conference support from the Canadian Public Health Association, outside the submitted work. She is the director of the AMMI Canada Council and a member of the Canadian Association for Immunization Research Evaluation and Education. Cora Constantinescu reports speaker fees from GSK and Pfizer. Cynthia Seow sits on the advisory boards for and reports speaker fees from Janssen, Abbvie, Takeda, Ferring, Shire, Pfizer, Sandoz, Pharmascience. No other competing interests were declared.
- Subjects :
- Adult
Antibodies, Monoclonal administration & dosage
Biological Products administration & dosage
Biological Products adverse effects
Female
Humans
Pregnancy
Pregnancy Complications epidemiology
Pregnancy Outcome epidemiology
Antibodies, Monoclonal adverse effects
Pregnancy Complications etiology
Subjects
Details
- Language :
- English
- ISSN :
- 1488-2329
- Volume :
- 193
- Issue :
- 29
- Database :
- MEDLINE
- Journal :
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
- Publication Type :
- Academic Journal
- Accession number :
- 34312166
- Full Text :
- https://doi.org/10.1503/cmaj.202391